Statement: the primary clinical trial routinely reports adverse events, as does the secondary clinical trial
Primary_evidence: Adverse Events 1:   Total: 0/23 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/655 (0.00%) Adverse Events 2:   Total: 0/580 (0.00%)